Your browser doesn't support javascript.
loading
Myricetin reverses epithelial-endothelial transition and inhibits vasculogenic mimicry and angiogenesis of hepatocellular carcinoma by directly targeting PAR1.
Wang, Ming; Ren, Shanfa; Bi, Zhun; Zhang, Liang; Cui, Mengqi; Sun, Ronghao; Bao, Jiali; Gao, Dandi; Yang, Bo; Li, Xiaoping; Li, Mingjiang; Xiao, Ting; Zhou, Hong-Gang; Yang, Cheng.
Affiliation
  • Wang M; State Key Laboratory of Medicinal Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, People's Republic of China.
  • Ren S; State Key Laboratory of Medicinal Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, People's Republic of China.
  • Bi Z; Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, People's Republic of China.
  • Zhang L; State Key Laboratory of Medicinal Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, People's Republic of China.
  • Cui M; Department of Thoracic Surgery, Tianjin First Central Hospital, Nankai University, Tianjin, People's Republic of China.
  • Sun R; State Key Laboratory of Medicinal Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, People's Republic of China.
  • Bao J; Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, People's Republic of China.
  • Gao D; State Key Laboratory of Medicinal Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, People's Republic of China.
  • Yang B; State Key Laboratory of Medicinal Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, People's Republic of China.
  • Li X; Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, People's Republic of China.
  • Li M; State Key Laboratory of Medicinal Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, People's Republic of China.
  • Xiao T; Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, People's Republic of China.
  • Zhou HG; Department of Thoracic Surgery, Tianjin First Central Hospital, Nankai University, Tianjin, People's Republic of China.
  • Yang C; Department of Thoracic Surgery, Tianjin First Central Hospital, Nankai University, Tianjin, People's Republic of China.
Phytother Res ; 36(4): 1807-1821, 2022 Apr.
Article in En | MEDLINE | ID: mdl-35229382
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Limits: Humans Language: En Journal: Phytother Res Journal subject: TERAPIAS COMPLEMENTARES Year: 2022 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Limits: Humans Language: En Journal: Phytother Res Journal subject: TERAPIAS COMPLEMENTARES Year: 2022 Document type: Article Country of publication: United kingdom